Word: oncologist
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Researchers such as Dr. David Sidransky, an oncologist at Johns Hopkins University, are searching for diagnostics that will pick up other cancers in their preliminary stages. Others are focusing on an even earlier stage, trying to lower the risk of developing cancer to begin with. Here the most exciting work centers on the cycooxygenase inhibitor called COX-2. This pain reliever was originally developed to clamp down on inflammation as aspirin does but without aspirin's tendency to eat through the lining of the stomach...
...wasn't the first to explore the link between mind and disease, but few practitioners have delved as deeply or successfully into the topic. Jeanne Achterberg was 32 when she read an article that described how oncologist Carl Simonton helped cancer patients fight malignancies not just by using medicine but also by drawing on their emotional reserves and the support of other patients. Achterberg, now 59, was so taken with this revolutionary notion that she sought out Simonton and his wife so she could work with them...
...wasn't the first to explore the link between mind and disease, but few practitioners have delved as deeply or successfully into the topic. Jeanne Achterberg was 32 when she read an article that described how oncologist Carl Simonton helped cancer patients fight malignancies not just by using medicine but also by drawing on their emotional reserves and the support of other patients. Achterberg, now 59, was so taken with this revolutionary notion that she sought out Simonton and his wife so she could work with them...
...patients in the U.S. each year. In the drug's very first test, every patient went into remission. In the most recent results, 30% showed no sign of the chromosomal damage that marks the disease and appeared to have been cured. "This drug is amazing," says Richard Stone, an oncologist at the Dana-Farber Cancer Institute who has been testing Glivec (also known as an STI, for signal transduction inhibitor). "Even patients who are near death, at the end stage of this disease, are going into remission...
...treatments will fail clinical trials. But doctors who treat the disease are experiencing a surge of optimism the likes of which they have never felt before. "It's no longer spin the wheel, let's try this drug, maybe it will work," says Henry Friedman, a neuro-oncologist at Duke University Medical Center. "We're going to know why a drug is or isn't working." And given the nature of cancer and the scientists who study it, if one approach doesn't fly, there will be no shortage of other ideas...